Saliva samples as a source of DNA for high throughput genotyping: an acceptable and sufficient means in improvement of risk estimation throughout mammographic diagnostics.

scientific article

Saliva samples as a source of DNA for high throughput genotyping: an acceptable and sufficient means in improvement of risk estimation throughout mammographic diagnostics. is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1103668851
P356DOI10.1186/S40001-018-0318-9
P2888exact matchhttps://scigraph.springernature.com/pub.10.1186/s40001-018-0318-9
P932PMC publication ID5921411
P698PubMed publication ID29703267

P50authorPeter A. FaschingQ64005064
Arif B. EkiciQ64409983
Matthias W. BeckmannQ72940290
P2093author name stringC C Hack
H Huebner
M Ruebner
U G Poehls
P2860cites workGene panel sequencing in familial breast/ovarian cancer patients identifies multiple novel mutations also in genes others than BRCA1/2.Q48361014
Volunteer's willingness to genetic testing - lack of the understanding of the matter.Q50723512
Psychosocial factors associated with the public's willingness to pay for genetic testing for cancer risk: a structural equations model.Q51066499
Breast cancer risk is associated with the genes encoding the DNA double-strand break repair Mre11/Rad50/Nbs1 complex.Q51903876
Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13.Q53464409
Increased Identification of Candidates for High-Risk Breast Cancer Screening Through Expanded Genetic Testing.Q53539898
Ten genes for inherited breast cancer.Q53571876
Quantity and quality assessment of DNA extracted from saliva and blood.Q54310072
Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.Q54361261
Public willingness to participate in and public opinions about genetic variation research: a review of the literatureQ56786711
Genetic testing for prostate cancer. Willingness and predictors of interestQ56947293
Evaluation ofRAD50 in familial breast cancer predispositionQ57266727
Saliva-Derived DNA Performs Well in Large-Scale, High-Density Single-Nucleotide Polymorphism Microarray StudiesQ57667565
Collection of genomic DNA from adults in epidemiological studies by buccal cytobrush and mouthwashQ58047464
TP53 mutations and abnormal p53 protein staining in breast carcinomas related to prognosisQ58143865
Mammographic density as a risk factor for breast cancer in a German case–control studyQ62583472
BRCA2 germline mutations in male breast cancer cases and breast cancer familiesQ71167609
TP53 abnormalities and genetic instability in breast cancerQ71712670
Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancerQ74299619
Breast cancer and genetic instability: the molecules behind the scenesQ74811100
The impact of breast cancer awareness and socioeconomic status on willingness to receive breast cancer prevention drugsQ79222959
Stage of breast cancers found during the surveillance of women with a familial or hereditary riskQ80446180
MRI surveillance for hereditary breast-cancer riskQ81776012
Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNAQ24569526
Quality and quantity of saliva DNA obtained from the self-administrated oragene method--a pilot study on the cohort of Swedish menQ28264408
Rare, evolutionarily unlikely missense substitutions in CHEK2 contribute to breast cancer susceptibility: results from a breast cancer family registry case-control mutation-screening studyQ28743906
Large-scale genotyping identifies 41 new loci associated with breast cancer riskQ29416989
Identification of the breast cancer susceptibility gene BRCA2Q29616290
Genetic variation and willingness to participate in epidemiologic research: data from three studiesQ31010279
Screening and genetic counselling for relatives of patients with breast cancer in a family cancer clinicQ33594506
The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotypeQ33904762
Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibilityQ33904964
Percent Mammographic Density and Dense Area as Risk Factors for Breast CancerQ34209634
Breast cancer in European Union: an update of screening programmes as of March 2014 (review)Q34372180
Cost sharing and hereditary cancer risk: predictors of willingness-to-pay for genetic testingQ35570884
Possible net harms of breast cancer screening: updated modelling of Forrest reportQ35603080
Mammographic Breast Density and Common Genetic Variants in Breast Cancer Risk PredictionQ35786337
Breast cancer surveillance in women with hereditary risk due to BRCA1 or BRCA2 mutationsQ35928599
Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancerQ35996692
Mammographic breast density and breast cancer: evidence of a shared genetic basisQ36043843
The contributions of breast density and common genetic variation to breast cancer riskQ36137764
Saliva samples are a viable alternative to blood samples as a source of DNA for high throughput genotypingQ36397260
Prediction of breast cancer risk based on profiling with common genetic variantsQ36583004
Clinical management recommendations for surveillance and risk-reduction strategies for hereditary breast and ovarian cancer among individuals carrying a deleterious BRCA1 or BRCA2 mutationQ36754871
Quality of DNA extracted from mouthwashesQ37240598
Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancerQ37373918
Breast Cancer Risk - From Genetics to Molecular Understanding of PathogenesisQ37660589
Hereditary breast and ovarian cancer susceptibility genes (review).Q38115459
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease StudyQ38787080
Mammographic density is the main correlate of tumors detected on ultrasound but not on mammographyQ39622978
Willingness to pay for genetic testing: a study of attitudes in a Canadian population.Q39905609
Attitudes toward genetic testing and personalised nutrition in a representative sample of European consumers.Q40050417
Codon 72 polymorphism of the TP53 geneQ40522948
Knowledge and willingness of breast cancer patients from Shanghai for genetic counseling and gene testingQ40601392
Mutation screening of Mre11 complex genes: indication of RAD50 involvement in breast and ovarian cancer susceptibilityQ43074406
Estimates, from salivary analyses, of the turnover time of the oral mucosal epithelium in humans and the number of bacteria in an edentulous mouthQ44414294
Evaluation of saliva as a source of human DNA for population and association studies.Q47211185
Influence of mammographic density on the diagnostic accuracy of tumor size assessment and association with breast cancer tumor characteristicsQ47318223
FOXP2 variants in 14 individuals with developmental speech and language disorders broaden the mutational and clinical spectrumQ48090851
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue1
P407language of work or nameEnglishQ1860
P304page(s)20
P577publication date2018-04-27
P1433published inEuropean Journal of Medical ResearchQ5412732
P1476titleSaliva samples as a source of DNA for high throughput genotyping: an acceptable and sufficient means in improvement of risk estimation throughout mammographic diagnostics.
P478volume23

Search more.